By implementing these changes, HB5833 seeks to promote fairness in pharmacy pricing and reimbursement practices. The bill requires that PBMs regularly update their maximum allowable cost pricing information and grants plan sponsors limited rights to audit compliance and transparency related to rebate amounts. Additionally, pharmacists may disclose whether a covered individual's cost-sharing exceeds retail prices, thus empowering them to provide cost-saving alternatives to patients. These changes are intended to foster a more competitive environment that benefits both pharmacies and consumers.
Summary
House Bill 5833, introduced by Rep. John M. Cabello, amends the Illinois Insurance Code to regulate pharmacy benefit managers (PBMs) more strictly, particularly regarding their contracts and practices. The bill specifically prohibits actions that restrict a covered individual's choice of pharmacies, defined as 'steering.' The outlined regulations aim to ensure that patients are not coerced into using specific pharmacies for their prescriptions, particularly those owned or controlled by the PBM. This prohibition will be effective from July 1, 2024.
Contention
Notable points of contention surrounding HB5833 primarily involve concerns from pharmacy benefit managers and their affiliates. They argue that the bill could increase operational burdens and restrict their ability to manage pharmacy networks effectively. Critics within the PBM sector worry that the changes may undermine their business models, particularly those that have developed proprietary pricing strategies. On the other hand, proponents assert that the bill is crucial for protecting consumers and ensuring that they are not subject to exploitative practices by entities that exert too much control over prescription pricing and accessibility.